CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Actelion Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 4, 2024Methods Of Treating Pulmonary Arterial Hypertension4
May 22, 2024Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension3
Jan 26, 2022Dosing Regimen For A Selective S1P1 Receptor Agonist2
Apr 21, 2021Pharmaceutical Composition Comprising Selexipag1
Oct 9, 2019Therapeutic Compositions Containing Macitentan3
Oct 25, 2017Therapeutic Compositions Containing Macitentan5

Top competitors of Actelion Pharmaceuticals

List of top competitors of Actelion Pharmaceuticals based on patent oppositions.